A detailed history of Amalgamated Bank transactions in Mannkind Corp stock. As of the latest transaction made, Amalgamated Bank holds 9,156 shares of MNKD stock, worth $55,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,156
Previous 9,156 -0.0%
Holding current value
$55,760
Previous $48,000 20.83%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.05 - $5.43 $1,802 - $2,416
445 Added 5.11%
9,156 $48,000
Q1 2024

Apr 23, 2024

SELL
$3.25 - $5.27 $81,588 - $132,298
-25,104 Reduced 74.24%
8,711 $39,000
Q4 2023

Feb 06, 2024

SELL
$3.34 - $4.29 $8,657 - $11,119
-2,592 Reduced 7.12%
33,815 $123,000
Q2 2023

Aug 11, 2023

BUY
$3.72 - $4.79 $32,092 - $41,323
8,627 Added 31.05%
36,407 $148,000
Q1 2023

May 02, 2023

SELL
$3.95 - $5.63 $25,501 - $36,347
-6,456 Reduced 18.86%
27,780 $114,000
Q4 2022

Feb 10, 2023

BUY
$3.02 - $5.37 $6,024 - $10,713
1,995 Added 6.19%
34,236 $180,000
Q3 2022

Nov 09, 2022

BUY
$2.99 - $4.35 $194 - $282
65 Added 0.2%
32,241 $100,000
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $3,687 - $6,587
1,381 Added 4.48%
32,176 $123,000
Q1 2022

Jun 30, 2022

SELL
$2.62 - $4.45 $6,605 - $11,218
-2,521 Reduced 7.57%
30,795 $113,000
Q4 2021

Feb 15, 2022

SELL
$4.05 - $5.37 $1,389 - $1,841
-343 Reduced 1.02%
33,316 $146,000
Q3 2021

Oct 29, 2021

SELL
$3.89 - $5.48 $8,709 - $12,269
-2,239 Reduced 6.24%
33,659 $146,000
Q2 2021

Aug 16, 2021

BUY
$3.61 - $5.45 $13,732 - $20,731
3,804 Added 11.85%
35,898 $196,000
Q1 2021

May 13, 2021

SELL
$3.14 - $6.14 $8,104 - $15,847
-2,581 Reduced 7.44%
32,094 $126,000
Q4 2020

Feb 12, 2021

BUY
$1.79 - $4.04 $1,321 - $2,981
738 Added 2.17%
34,675 $108,000
Q3 2020

Oct 30, 2020

BUY
$1.56 - $2.08 $347 - $463
223 Added 0.66%
33,937 $64,000
Q2 2020

Aug 10, 2020

BUY
$0.94 - $2.21 $397 - $934
423 Added 1.27%
33,714 $59,000
Q1 2020

May 13, 2020

BUY
$0.84 - $1.76 $135 - $283
161 Added 0.49%
33,291 $34,000
Q3 2019

Nov 13, 2019

SELL
$1.04 - $1.44 $301 - $417
-290 Reduced 0.87%
33,130 $41,000
Q2 2019

Aug 14, 2019

BUY
$1.09 - $1.88 $12,121 - $20,907
11,121 Added 49.87%
33,420 $38,000
Q1 2019

May 15, 2019

BUY
$1.14 - $2.25 $921 - $1,818
808 Added 3.76%
22,299 $44,000
Q4 2018

Feb 15, 2019

BUY
$1.02 - $2.05 $21,920 - $44,056
21,491 New
21,491 $23,000
Q3 2018

Nov 14, 2018

SELL
$1.01 - $2.19 $22,018 - $47,742
-21,800 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$1.59 - $2.38 $34,662 - $51,884
21,800 New
21,800 $41,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.